Literature DB >> 15065193

Pre-eclampsia and peripartum cardiomyopathy in molar pregnancy: clinical implication for maternally imprinted genes.

M-H Billieux1, P Petignat, A Fior, P Mhawech, J-L Blouin, S Dahoun, P Vassilakos.   

Abstract

Molar pregnancies are associated with increased maternal complications, notably pre-eclampsia, but peripartum cardiomyopathy has been rarely observed. Here we report on a 34-year-old woman, gravida 2 para 1, who presented to our obstetric clinic for routine screening at 16 weeks of gestation. Elevated maternal serum alpha-fetoprotein and free beta-human chorionic gonadotropin were observed. Amniocentesis revealed a triploid constitution (69,XXX) and ultrasound examination showed growth restriction, fetal anomalies, placentomegaly and a total placenta previa. On admission at 18 weeks' gestation, the patient developed vaginal bleeding and pre-eclampsia. She underwent a Cesarean delivery and 6 h later developed congestive heart failure requiring intensive care support. Molecular analysis of the conceptus and parental DNA demonstrated an excess of paternal genomic contribution. The over-representation of the paternal chromosome complement may support the role of genomic imprinting in the clinical course of this case. Copyright 2004 ISUOG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065193     DOI: 10.1002/uog.1015

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  3 in total

Review 1.  The Role of Genetics in Peripartum Cardiomyopathy.

Authors:  Yi Zhen Joan Lee; Daniel P Judge
Journal:  J Cardiovasc Transl Res       Date:  2017-08-03       Impact factor: 4.132

2.  A complex obstetric case.

Authors:  Michael Hoy; Kate Flavin; Venkat Prasad
Journal:  J Intensive Care Soc       Date:  2017-04-03

3.  Maternal complications in molecularly confirmed diandric and digynic triploid pregnancies: single institution experience and literature review.

Authors:  D Massalska; J Bijok; A Kucińska-Chahwan; J G Zimowski; K Ozdarska; A Raniszewska; G M Panek; T Roszkowski
Journal:  Arch Gynecol Obstet       Date:  2020-03-26       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.